Embryonic striatal graft-mediated functional recovery in the rodent lesion model of Huntington's disease (HD) has been shown to correlate with the proportion of dopamine-and adenosine 3′,5′-monophosphateregulated phosphoprotein with a molecular weight of 32 kDa (DARPP-32)-positive neurons in the graft. The current study investigated the impact of graft distribution on the yield of DARPP-32-positive cells in the grafts following either single-tract or multitract cell delivery protocols using the microtransplantation approach. Cells derived from the whole ganglionic eminence of E15 rat embryos, ubiquitously expressing green fluorescent protein (GFP), were implanted into unilaterally QA-lesioned rat striatum either as 2 × 1.8 µl macrodeposits in a single tract, or as 18 × 0.2 µl microdeposits disseminated over six needle, multitract, penetrations. For both groups, an ultrathin glass capillary with an outer diameter of 50 µm was used. Histological assessment at 4 months after transplantation showed nearly twofold increase of DARRP-32-positive striatal-like neurons in the multitract compared to the single-tract group. However, the cellular make-up of the grafts did not translate into functional differences as tested in a basic spontaneous behavior test. Furthermore, the volumetric values for overall volume, DARPP-32-positive patches, and dopaminergic projection zones were similar between both groups. The results show that distribution of fetal striatal tissue in multiple submicroliter deposits provides for an increased yield of striatal-like neurons, potentially due to the enlargement of the graft-host border area intensifying the graft's exposure to host-derived factors. Furthermore, the use of embryonic tissue from GFP donors was validated in cell-based therapy studies in the HD model.
INTRODUCTION
In former studies, it has been shown that graftinduced functional recovery in animal experiments relates directly to the quantity of striatal medium spiny Cell transplantation as a therapeutic approach for Huntington's disease (HD), an inherited neurodegenera-projection neurons stained positive for DARPP-32 (dopamine-and adenosine 3′,5′-monophosphate-regulated tive disorder, has the potential to replace damaged striatal neurons, which can lead to reestablishment of dys-phosphoprotein with a molecular weight of 32 kDa) within the transplant (16, 25, 37) . As reported by different functional neuronal circuits resulting in partial behavioral recovery (4, 29, 38) . This concept has advanced beyond groups for the quinolinic acid (QA)-induced excitotoxic rat model of HD, the number of DARPP-32-positive animal experimentation and into the clinic where trials in patients have moved forward (6, 13, 26) . However, cells in the grafts derived from the lateral ganglionic eminence (LGE) is estimated to range between 10% and there are still many issues to be dealt with, not the least of which is an optimized transplantation protocol to en-40% with respect to the primary pregrafting cell population (35, 37, 57) . This proportion is considered to be con-hance the yield of relevant cell populations within the graft.
stituted by a combination of cell survival versus cell death on the one hand, and proliferation of grafted pro-Experimental Design genitor cells, which continue to divide and mature post-
The experimental design is summarized in Table 1 . transplantation (25) , on the other hand.
A total of 59 adult female Sprague-Dawley rats (Charles Taking into account the considerably high loss of River, Germany) weighing 225-250 g at the beginning DARPP-32-positive cells following transplantation, the of the study were used in the study, and were distributed correlative relationship between the quantity of this releinto control (n = 15), lesion-only (n = 14), multitract vant cell population and behavioral recovery implies the (MT, n = 15), or single-tract (ST, n = 15) grafting group. potential and the importance of further improvement of cellular availability. Nevertheless, approaches to in-Lesion crease the yield of functionally important cells have Two investigators carried out the lesion procedure rather been in the periphery of HD cell therapy research over 1 day using one single preparation of quinolinic while being a central issue of interest for Parkinson's acid. In order to secure a stable and comparable lesion disease (PD). (30) , the lesion surgery, as well as all other surgical pro-With the objective to enhance survival of implanted cedures, was performed under inhalative gas anesthesia dopaminergic cells, Nikkhah and colleagues introduced with isoflurane (Abbott, Germany) using O 2 as carrier a microtransplantation protocol to the 6-OHDA animal gas (induction: 5 vol% of isoflurane with 1.5 L O 2 per model of PD using a glass capillary with a relatively minute; maintenance: 1.5-2.0 vol% isoflurane in 1.5 L small outer diameter of 50 µm as a novel transplantation O 2 per minute). device for cell suspension grafting (41, 42, 52) . With this Using a stereotactic frame (Stoelting, USA), animals minimally traumatic and accurate technique it was possireceived unilateral striatal lesions by injecting 4 × 0.2 µl ble to establish a multitract transplantation protocol, alof 0.12 M quinolinic acid (Sigma, USA) dissolved in lowing for a wider dissemination of the cell suspension 0.1 M phosphate-buffered saline (1 × PBS solution), pH as multiple microdeposits. The combination of both the 7.4, at two depths in each of the two tracks in the left refinement of the injection instrument and the novel neostriatum. Each injection was infused over 90 s via a placement strategy was shown to lead to significant im-26-gauge stainless steel cannula connected to a 10-µl provement of graft survival and a more extensive behav-Hamilton syringe (Hamilton Europe, Switzerland), which ioral recovery in animal models of PD (41, 42, 52) .
was placed on a micropump (World Precision Instru-In the current study, hypothesizing that similar bioments Inc., UK). In total, the animals received 0.8 µl of logical factors accounting for the positive outcome on 0.12 M quinolinic acid solution (=96 nmol of QA in key neuronal phenotype in PD may also be relevant in total) with an injection rate of 0.13 µl/min. Injection cothe HD model, we transferred the multitract microtransordinates with measurements in mm anterior (A) in front plantation approach to the QA-induced excitotoxic rat of bregma, lateral (L) to the midline, vertical (V) below model. To investigate the impact of graft distribution dura were: A = −0.4, L = +3.7, V = 5.2/4.2; A = +1.2, L = on the yield of DARPP-32-positive neurons in the graft, +2.9, V = 5.2/4.2. The inter-aural line was set at 2.3 unilateral striatal lesioned rats were transplanted with mm. The cannula was held in place for 2 min before equal numbers of E15 cells derived from the whole ganretraction to reduce leakage. While still under anestheglionic eminence (WGE) either in one injection tract sia, the animals received SC Temgesic (0.05 mg bupren-(single tract or ST-group) with two large deposits or in orphin hydrochlorid/kg body weight; Essex Pharma, six injection tracts (multitract or MT-group) with 18
Germany) in the neck as postsurgical analgesic. small deposits. Histological analysis confirms that the multitract protocol can positively influence the development of DARPP-32-positive neurons within the grafts. 
Breeding, Dissection, and Single Cell Suspension
After each tract, the capillary was kept in place for 2 min, then slowly retracted and rinsed with medium. The Inbred heterozygous green fluorescent protein (GFP)animals underwent the same postoperative treatment as transgenic Lewis rats were used as cell donors. Kindly described for the lesion. In the present study, two differprovided by Dr. Eiji Kobayashi, the transgenic animals ent transplantation protocols were used constituting the express GFP under the control of a cytomegalovirus two transplantation groups (the distribution of transplan-CMV/β-actin promoter (CAG promoter) (22, 28) . Wildtation deposits for both transplantation groups is illustype Lewis rats were purchased from Charles River, trated in Fig. 1C, D) . Germany, and bred with heterozygous GFP-transgenic animals to maintain the strain. Graft tissue was obtained Single-Tract Transplantation Group. Two macrodefrom the WGE of E15 heterozygous GFP-transgenic posits of 1.8 µl each (total of 3.6 µl) were implanted in Lewis rat embryos.
the lesion area using one tract. Stereotactic implantation Fifteen days before harvesting the embryos, one wildcoordinates in mm were: A = +0.4, L = +3.3, V = 5.0/ type Lewis GFP −/− male with normal phenotype was 4.4. The interaural line was set at 2.3 mm. bred overnight with one or two GFP (GFP +/− )-transgenic Multitract Transplantation Group. Eighteen microfemales. The following day was counted as day 0. At deposits of 0.2 µl each (total of 3.6 µl) were implanted gestation age E15, the embryos had a crown-rump in the lesion area using six tracts (three deposits per length (CRL) of 13-14 mm (45, 49) . The abdomens of tract). Transplantation coordinates exhibited in mm were: the deeply anesthetized pregnant animals were opened, A = +1.0, L = +2. Histology and Image Analysis bilaterally only from E15 GFP-transgenic embryos. Dis-Sixteen weeks following the intrastriatal grafting, the sected tissue was collected and preserved in a 0.5-ml animals were terminally anesthetized by intraperitoneal Eppendorf tube containing 0.1% DNase diluted in (IP) injection of an overdose of ketamine (Essex Pharma, HBSS. Pooled striatal ganglionic eminences were incu-Germany) and rompun (Bayer, Germany) and then transbated in 0.1% trypsin and 0.05% DNase for 20 min at cardially perfused with 300 ml 0.1 M PBS followed by 37°C. The suspension was then rinsed four times in 300 ml 4% paraformaldehyde in 0.1 M PBS. The brains 0.05% DNase diluted in HBSS. Following centrifugawere removed and postfixed in 4% paraformaldehyde tion at 1000 rpm for 4 min, the supernatant was removed for 1.5 h, then immersed in 30% sucrose in 0.1 M PBS and the tissue was mechanically triturated using flamefor 24 h until they had sunk. Tissue was serially secpolished 1000-µl and 200-µl pipette tips.
tioned on a freezing microtome at a thickness of 40 µm Viability of the embryonic cells was assessed by trythrough both the striatum and substantia nigra and colpan blue exclusion just prior to grafting using a hemocylected as six series. tometer and was always more than 97% for these striatal Free-floating sections were washed three times with cell suspensions. The resulting single cell suspension PBS, preincubated for 2 h in 3% bovine serum albumin was adjusted to a concentration of 130,000 cells/µl. Cell (BSA; Sigma, Germany)/0.3% Triton X-100 (Sigma)/ viability was again monitored at the end of the trans-PBS, and incubated overnight at room temperature with plantation procedure and was more than 90%. the primary antibodies: GFP (mouse anti-GFP, 1:500; Transplantation Procedure Invitrogen, Germany), NeuN (mouse anti-NeuN, 1:1000; Chemicon, Germany), a marker of mature neurons, Transplantation surgery was carried by two people during 1 day, with animals from the two grafted groups DARPP-32 (rabbit anti-DARPP-32, 1:500; Chemicon), a marker of striatal tissue (17-19,31,46), and tyrosine equally matched between both investigators. Transplantation in both grafted groups was performed using a hydroxylase (mouse anti-TH, 1:500; Sigma), a marker used to identify dopaminergic neurons and axonal input. glass capillary with a diameter of 50 µm connected via an adaptive polyethylene tube to the cannula of a 2-µl After three washes with PBS, sections were incubated for 2 h with biotinylated secondary antibody (1:200; Hamilton syringe (41,42,44) ( Fig. 1A, B ). Host animals were anesthetized using isoflurane as described above Dako, Germany) for DAB staining or with an Alexa secondary antibody (Alexa Fluor, 1:200; Invitrogen) for and positioned in the stereotactic frame. After rinsing the capillary with cell-free medium, the single cell sus-fluorescence staining. Visualization for the biotinylated antibody was carried out with the ABC kit (Vector, Ger-pension was aspirated into the glass capillary and placed into the left neostriatum according to the group protocol. many) and DAB (Merck, Germany). Sections were mounted on slides, dehydrated, and cover slipped, and tions. The extent of the lesion in the dorsal striatum was estimated by tracing the outlines of each section subjected to image analysis (Olympus Ax-70; "Analysis," Soft Imaging Systems, Germany). Fluorescence throughout the anterior-posterior axis of the striatum on the DARPP-32-stained sections giving the cross section staining was used for confocal microscopy pictures illustrating DARPP-32 GFP coexpression; all quantitative areas. The volumes for the various parameters measured were calculated by taking into account the sum of the measurements were carried out with DAB-stained sec-areas and correcting for section thickness and sample ANOVA test was applied for the Table lift test, using as main effects the Groups (control, lesion, MT, ST) and the frequency [volume (mm 3 ) = sum of areas (mm 2 ) × 40 µm × 6). Confocal microscopy pictures were taken from Sessions (baseline, postlesion, and posttransplantation 1 and 2). In case of main effects, the Newman-Keuls post immunofluorescence-stained sections using a Leica TCS SP2 AOBS spectral confocal microscope.
hoc analysis was used to identify the significant differences. Level of significance was set at p < 0.05 for all DARPP-32 Cell Count tests. Results are expressed as mean ± SEM. Cell counting was performed using a Leica DMRB microscope with the Stereo Investigator software.
RESULTS DARPP-32-positive cells were counted from all moun-Histology ted sections containing a graft in a 1:6 series from all Photomicrographs of the control, the lesioned, and transplanted animals. The Abercrombie formula for corthe grafted animals are shown in Figure 2 . The volumetrection of cell counts was used to obtain estimates of ric measurements are summarized in Table 2 . total cell numbers from the raw cell counts. The corrected cell number P was calculated by the formula:
where A is the cell count from the Quinolinic acid injections resulted in a marked unilatentire graft, f is the frequency of sections, M is the seceral cell loss and local atrophy in the striatum, which tion thickness, and D is the average cell diameter. The could be visualized immunohistochemically with the proportion of cells coexpressing DARPP-32 and GFP adult neuronal marker NeuN and the striatal marker was evaluated during counting on DARPP-32-stained DARPP-32 ( Fig. 2D, E) . sections, as the GFP signal could be clearly detected
The volumetric measurements (mm 3 ) were carried out using autofluorescence.
using NeuN-stained sections quantifying the extent of the lesion by subtracting the absolute volume of the sur- Table Lift Behavior Test viving ipsilateral striatum from the contralateral unaf-Table lift is a spontaneous behavior task looking at fected one serving as control. the rats' ability to make adjustment movements with its
In both the lesion and the treatment groups, the toxin forepaws (14) . The animal's hindlimbs and one of the equally reduced the ipsilateral striatal volume to 31 As expected, there was no scored according to a system ranging from 0 to 3 acdifference in the volume of the intact contralateral striacording to the following: (0) no reaction-the animal tum across the lesioned groups as this side was not afignores the stimulation and makes no attempt to make fected by the lesion [Groups, F(1, 22) = 0.06, p > 0.05, contact with the table using its free forelimb; (1) muscle n.s.). reaction without reaching-the animal turns its head towards the table or shows movement in the free paw Graft without successfully reaching the table;
(2) delayed re-NeuN-stained sections were used to measure the total action with the free limb making successful contact with volume of the graft because it allowed unambiguous the table-the animal reaches with a temporal delay to identification of the boundary between the graft, the the table, but only in the upper part of the edge; (3) neuron-depleted lesioned area, and the remaining host prompt reaction with the free limb making successful tissue (Fig. 2G, J) . The grafts survived in the host striacontact with the table-the animal reaches immediately tum, were rich in cells of neuronal morphology, as seen to the table and tries to hold it.
in the NeuN sections, and exhibited a characteristic This test was repeated five times per day during the patchy staining with DARPP-32, a selective marker for testing sessions on each forelimb for 1 day and the final the striatal-like neurons within the grafts (Fig. 2I, L, O) . results are expressed as the sum of 1 day. Table lift test Transplants of both groups exhibited a regular dropwas performed prelesion, pregrafting, and 8 weeks follike configuration (Fig. 2G-L) , which suggests that durlowing transplantation.
ing maturation the 18 microdeposits of the MT grafts Statistical Analysis merged into a unit with a continuous graft-host border making it impossible to distinguish between individual Statistical analyses was carried out with StatView software (Abacus, USA) using the ANOVA test. A multiple deposits. MT and ST grafts also had similar overall graft vol-is comparable to unpublished results from our lab where GFP-positive dopamine-rich single cell suspensions umes, as measured by NeuN staining, as well as comparable DARPP-32 positive patch volumes [ Table 2: were transplanted in the 6-OHDA lesion model of PD.
In this latter study, 80% of the grafted dopaminergic Groups graft volume, F(1, 24) = 0.25, p > 0.05, n.s.; Groups DARPP-32-patch/nonpatch volume, F(1, 24) = TH-positive cells maintained a stable GFP expression, which was independent of immunosuppressive treatment 0.9, p > 0.05, n.s.]. The pattern of dopaminergic input to the graft, identified by the TH-positive fiber staining, with cyclosporine, even though, as in the present experiment, GFP-transgenic Lewis rat tissue was allografted coincided with the DARPP-32-positive patches and exhibited comparable mean values in both transplanted in Sprague-Dawley rats (Krause et al., manuscript in preparation). With the current experiment we validated groups [ Table 2 : Groups TH patch/nonpatch volume, F(1, 24) = 1.44, p > 0.05, n.s.].
the use of embryonic tissue from GFP donors in cellbased therapy studies in the HD lesion model and GFP Expression of the Graft showed the potential of this cell source as a new and valuable means to stably visualize and identify most of In unstained sections using GFP autofluorescence as well as in immunohistochemically enhanced ones using the transplanted cells. Sections stained for GFP as a transplant-specific primary GFP antibodies, the expression of the GFP remained stable (Fig. 3) . Coexpression analysis revealed marker were used to assess the dissemination and axonal projection profile of the implanted cells ( Fig. 4) . All that 84% of the counted DARPP-32-positive cells within the graft were also GFP positive 16 weeks after grafting, grafts exhibited a homogenous GFP staining and no apparent cell migration was found (Fig. 4B ). Furthermore, independent of the respective implantation protocol. This means that, in the process of graft maturation, only analyzing the local extension of GFP-positive axonal fibers, a vast innervation of the striatum throughout the 16% of the striatal cells lost their GFP expression, which whole anterior-posterior axis and even adjacent areas grafts exhibited a significantly higher density of DARPP-32-positive cells/mm 3 patch volume [Groups, F(1, 24) = by grafts of both transplantation groups was noted (Fig.  4A ). 8.14, p < 0.05] (Fig. 5B ).
Behavioral Evaluation: Table Lift Test Cell Counting of DARPP-32-Positive Neurons
The results of the table lift test are shown in Figure  Using the Abercrombie correction formula, the total 6. At baseline, all animals reached the maximum of 15 number of DARPP-32-positive cells was calculated for points. The lesion surgery induced a significant decrease both therapeutic groups. As shown in Figure 5 , the rein the contralateral paw performance in all of the experisults reveal a significant 1.8-fold higher number of mental groups compared to the controls; this functional DARPP-32-positive cells in the MT compared to the ST deficit was subsequently reversed to control levels in the group [Groups, F(1, 24) = 8.62, p < 0.05]. Given similar grafted groups in both posttransplantation sessions, with graft volumes, the significantly higher DARPP-32-posino functional differences between the MT and the ST tive cell count implies that this cell type benefited particgroups [Groups × Sessions, F(9, 147) = 8.88, p < 0.001; ularly and more than others from the MT protocol. This post hoc: Baseline, no significant differences; Post-les, corresponds with the observation that P zones in the MT control > lesion/MT/ST, p < 0.001; Post-tx1 and Post-tx2, control/MT/ST > lesion, p < 0.001].
DISCUSSION
The present study, using a rodent model of Huntington's disease (HD), demonstrates that a multiple placement strategy of striatal neural progenitor cells distributed over 18 implantation sites as small submicroliter deposits leads to a higher total number of DARPP-32positive cells when compared to a standard single-tract macrodeposit protocol with only two implantation sites. This strategy is already applied in some current clinical trials on fetal cell transplantation for HD patients using four or five trajectories (for eight deposits each) per side (5, 13) . As indicated by the literature, there is evidence for a correlative relationship between the amount of DARPP-32-positive cells within a transplant and the functional recovery mediated by the grafts (16, 24, 37) . These data emphasize the importance of further optimizing the yield of functionally relevant cell populations for the clinical context and underlines the significance of the present study, even though a protocol-specific behavioral impact was not observed in the table lift test. One possible explanation could be the low sensitivity of this test that is based on simple spontaneous behavior. Furthermore, the use of embryonic tissue from GFP donors was validated in cell-based therapy studies in the HD model.
The novel implantation strategy protocol, as well as the microtransplantation device were adopted from preclinical studies in Parkinson's disease (PD) where the combination of both was shown to lead to significant improvement of dopaminergic graft survival (41, 42, 52) . The similar findings converging from both the HD and the case of PD, consensus has emerged that specific con- Table Lift test scores reveal an equal baseline, a significant reduction of performance following lesioning in the lesioned groups, and a graft-related recovery in both transplantation groups. No significant protocol-specific difference regarding Table Lift performance was detected, meaning that the increased DARPP-32-positive cell yield in the MT group did not translate into a functional improvement. Data represent group means ± SEM. MT, multitract; ST, single tract. **p < 0.001. ditions associated with the transplantation procedure and with the caspase inhibitor acetyl-tyrosinyl-valyl-alanylaspartyl-chloromethyl-ketone (Ac-YVAD-cmk). Com-posttransplantation interval including hypoxia/ischemia, trophic factor withdrawal, and oxidative stress render parable experiments with the potentially neuroprotective substance ciliary neurotrophic factor (CNTF) (48) , the grafted cells susceptible for early cell death (1). Neuroprotective treatment strategies were developed and suc-spin-trapping agent α-phenyl-tert-butyl nitrone (PBN) (37) , the NMDA receptor blocker MK-801, or the lazar-cessfully tested that aim to reduce these detrimental triggers, which led to higher survival rates [for review see oid U-83836E (34) have failed to produce evidence of neuroprotection of the striatal cells under the applied (10,51)]. In this context, Nikkhah and coworkers identified the modification of the grafting procedure as one of conditions. As an easily applicable alternative avoiding the use these strategies, demonstrating that using the multitract microtransplantation, as opposed to the single-tract mac-of additional substances, the multitract microtransplantation protocol is a modification of the grafting procedure, rotransplantation protocol, positively impacts on dopamine neuron survival, producing more consistent and based on the principle that a defined amount of cells is more widely distributed and organized in smaller sub-complete reinnervation of the denervated striatum, while reducing the overall host tissue trauma and subsequent units. This, per definition, leads to an enlargement of the graft-host border area (mathematically, given identical MHC and GFAP expression (9, 41, 43) . For HD cell therapy, only few factors were identified to significantly in-total volumes, the surface area of 18 spherical bodies is more than twofold larger than of two spherical bodies). crease DARPP-32-positive cell availability, reflecting the lack of emphasis given to this question to date. The Consequently, the proportion of cells at or in close proximity to the enlarged graft-host border increases, inten-age of donor tissue (23,54) and the grafting medium (55) were proven to influence the DARRP-32-positive cell sifying the graft's exposure to factors provided by the host. A time course analysis looking at when the MT yield; also, the extent of the QA lesion providing the environment in which the graft is placed into was posi-grafted tissue merges is required to confirm the suggestion that an increased graft-host border can be a factor tively correlated with the number of striatal neurons (56).
Applying a more active neuroprotective approach, in the graft development.
One host-derived neuroprotective key factor could be Mundt-Petersen and colleagues (35) showed a significantly positive effect when pretreating the graft tissue a protocol-related acceleration and enhancement of graft vascularization, as the predominantly host-derived ves-paminergic cell survival following microtransplantation is paralleled by a more discrete GFAP expression, both sels (7) penetrate and supply the primarily avascular and critically hypoxic cell suspension graft from the periph-around the implantation tract and around the implants, when compared to grafts where the standard metal can-ery towards the center of each deposit (15) . Therefore, more cells being in close proximity to the host-trans-nula was used (42) . However, we can only speculate about the influence of the grafting device on the out-plant border could be rescued from ischemic cell death by receiving vascular connections at an earlier posttrans-come of the present experiment, as the study design did not include the comparison between glass capillary and plantation time point. That vascularization is essentially important for graft development is supported by studies metal cannula. Nevertheless, we hypothesize that the microtransplantation technique may be a necessary prereq-in PD showing improved survival following enhancement of blood supply to the implanted cells (21, 32) .
uisite for the positive outcome of the multitract protocol as it might partially attenuate possible detrimental ef-Besides the obvious relevance of host-derived vasculature, it is clear that the surrounding host tissue substan-fects related to multiple insertion traumas.
Overall, clinical and preclinical experience suggests tially influences the graft's development. This is implied by several experiments showing a positive correlation that there are three important factors influencing the outcome of clinical transplantation protocols: i) graft between the intensity of the QA lesion and the DARPP-32-positive cell yield, which may be based on enhanced size-it appears that multiple smaller deposits give better outcome then fewer larger ones, perhaps due to the neurotrophic activity following brain injury (35, 56) . There is a marked accumulation of macrophages, acti-better vascularization that leads to increased access to nutrients and trophic elements; ii) graft distribution-vated microglia, and astrocytes beyond 1 week after injection of QA in the striatum (20) , which have been the grafted tissue needs to be placed over a sufficient area, and for this reason single deposits are not clinically shown to express growth factors like BDNF and GDNF (8), CNTF (3), and bFGF (27). Specifically, following relevant; and iii) instrument size-the instruments used have been adopted and reduced in diameter in the clinic QA injection, increased expression of NGF (12) in the striatum and BDNF (11) in the cortex was measured.
over time since the early clinical studies and are constantly being refined based on knowledge gained form Many publications report neuroprotective effects of these substances on striatal neurons in vitro and in vivo: basic research and from clinical work.
In conclusion, the current study demonstrates that by CNTF (47) and BDNF (36, 39) protect striatal neurons from NMDA-mediated toxicity; bFGF promotes the sur-varying the distribution of graft deposit sites, and the number of embryonic striatal cells deposited per site, the vival of DARPP-32-positive neurons exposed to serum withdrawal and NMDA (40) ; and delivery of the factors transplantation protocol can have a significant impact on the yield of functionally important striatal-like neurons prior to QA lesioning can lead to reduced excitotoxic neuronal damage [for review see (2)].
that develop within the transplant. The biological mechanisms supporting the finding remain to be elucidated, The influence of growth factors may be particularly important for striatal grafts where, in contrast to E14 do-but the understanding of this phenomenon could have important translational value in refining transplantation paminergic transplants (50), a subgroup of the transplanted progenitor cells continues to divide in the host protocols in the clinical application of cell based therapies for HD. brain (25) . There, the proliferating cells need to differentiate and to undergo an appropriate neuronal maturation ACKNOWLEDGMENTS: We thank Joanna Garcia and Beate program, which may be influenced or controlled by host Schmitt for their technical support and Eiji Kobayashi for providing us with the GFP transgenic animals. Wei Jiang was factors like BDGF that has been identified to stimulate the financially supported by the Stereotactic Neurosurgery Demorphological differentiation of striatal neurons (33, 53) . partment, University Hospital Freiburg, Germany.
As the described growth factor-mediated neuroprotective effects are linked to the quinolinic acid lesion, REFERENCES the question arises to what extent the assumed multitract
